HomeCompareLBYAV vs MRK

LBYAV vs MRK: Dividend Comparison 2026

LBYAV yields 18.37% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LBYAV wins by $9.2K in total portfolio value
10 years
LBYAV
LBYAV
● Live price
18.37%
Share price
$10.89
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$66.0K
Annual income
$5,637.49
Full LBYAV calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — LBYAV vs MRK

📍 LBYAV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLBYAVMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LBYAV + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LBYAV pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LBYAV
Annual income on $10K today (after 15% tax)
$1,561.07/yr
After 10yr DRIP, annual income (after tax)
$4,791.87/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $3,536.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LBYAV + MRK for your $10,000?

LBYAV: 50%MRK: 50%
100% MRK50/50100% LBYAV
Portfolio after 10yr
$61.4K
Annual income
$7,717.82/yr
Blended yield
12.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LBYAV
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LBYAV buys
2
MRK buys
0
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$LBYAV▼ Sell$1,001 - $15,0002024-11-13
Thomas H. Kean🏢 House$LBYAV▼ Sell$15,001 - $50,0002024-11-13
Ro Khanna🏢 House$LBYAV▼ Sell$1,001 - $15,0002024-01-10
Ro Khanna🏢 House$LBYAV▼ Sell$1,001 - $15,0002023-11-03
Ro Khanna🏢 House$LBYAV▼ Sell$15,001 - $50,0002023-10-10
Daniel Goldman🏢 House$LBYAV▼ Sell$1,001 - $15,0002023-07-12
Ro Khanna🏢 House$LBYAV▲ Buy$1,001 - $15,0002022-09-29
Ro Khanna🏢 House$LBYAV▲ Buy$15,001 - $50,0002022-09-29
Ro Khanna🏢 House$LBYAV▼ Sell$1,001 - $15,0002022-01-21
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLBYAVMRK
Forward yield18.37%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$66.0K$56.8K
Annual income after 10y$5,637.49$9,798.13
Total dividends collected$35.9K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LBYAV vs MRK ($10,000, DRIP)

YearLBYAV PortfolioLBYAV Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,537$1,836.55$11,206$366.19+$1.3KLBYAV
2$15,566$2,151.77$12,650$502.35+$2.9KLBYAV
3$19,152$2,496.94$14,407$694.19+$4.7KLBYAV
4$23,364$2,871.27$16,585$967.82+$6.8KLBYAV
5$28,273$3,273.57$19,342$1,363.89+$8.9KLBYAV
6$33,955$3,702.22$22,913$1,947.19+$11.0KLBYAV
7$40,487$4,155.28$27,662$2,823.89+$12.8KLBYAV
8$47,952$4,630.53$34,159$4,173.35+$13.8KLBYAV
9$56,434$5,125.48$43,337$6,308.80+$13.1KLBYAV
10$66,021$5,637.49$56,776$9,798.13+$9.2KLBYAV

LBYAV vs MRK: Complete Analysis 2026

LBYAVStock

Liberty Global Ltd., together with its subsidiaries, provides broadband internet, video, fixed-line telephony, and mobile communications services to residential and business customers. It offers value-added broadband services, such as WiFi features, security, anti-virus, firewall, spam protection, smart home services, online storage solutions, and web spaces; and Connect Box that delivers in-home Wi-Fi service. The company provides various tiers of digital video programming and audio services, as well as digital video recorders and multimedia home gateway systems; Horizon 5, a cloud-based, multi-screen entertainment platform that combines linear television, including recording and replay features and video-on-demand services; Horizon Go, an online mobile app; and channels, including general entertainment, sports, movies, series, documentaries, lifestyles, news, adult, children, and ethnic and foreign channels. In addition, it offers postpaid and prepaid mobile services; circuit-switched telephony services; and personal call manager, unified messaging, and a second or third phone line at an incremental cost. Further, the company offers business services comprising voice, advanced data, video, wireless, cloud-based services, and mobile and converged fixed-mobile services to small or home offices, small businesses, and medium and large enterprises, as well as on a wholesale basis to other operators. It operates in Belgium, Switzerland, Ireland, Slovakia, and internationally. Liberty Global Ltd. was founded in 2004 and is based in Hamilton, Bermuda.

Full LBYAV Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this LBYAV vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LBYAV vs SCHDLBYAV vs JEPILBYAV vs OLBYAV vs KOLBYAV vs MAINLBYAV vs JNJLBYAV vs ABBVLBYAV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.